Page last updated: 2024-09-04

pomalidomide and nsc 664704

pomalidomide has been researched along with nsc 664704 in 1 studies

Compound Research Comparison

Studies
(pomalidomide)
Trials
(pomalidomide)
Recent Studies (post-2010)
(pomalidomide)
Studies
(nsc 664704)
Trials
(nsc 664704)
Recent Studies (post-2010) (nsc 664704)
62312155295050

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)nsc 664704 (IC50)
nuclear receptor subfamily 0 group B member 1Homo sapiens (human)0.8335
Cyclin-T1Homo sapiens (human)0.064
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.4
Tyrosine-protein kinase LckHomo sapiens (human)0.47
Cyclin-dependent kinase 1Homo sapiens (human)0.4
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 21.5
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.4
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.4243
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.064
Glycogen synthase kinase-3 betaRattus norvegicus (Norway rat)0.4243
Cyclin-A2Homo sapiens (human)0.73
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.064
Cyclin-dependent kinase 2Homo sapiens (human)0.73
Mitogen-activated protein kinase 1Homo sapiens (human)9
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.064
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.023
Glycogen synthase kinase-3 betaHomo sapiens (human)0.0657
Cyclin-dependent kinase 9Homo sapiens (human)0.064
Cyclin-A1Homo sapiens (human)0.73
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.6314
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.6314
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.4
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.4243

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Feng, F; Jiang, X; Liu, X; Sun, H; Wang, Y; Xu, J; Xu, K; Zhou, J1

Other Studies

1 other study(ies) available for pomalidomide and nsc 664704

ArticleYear
PROTACs suppression of GSK-3β, a crucial kinase in neurodegenerative diseases.
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Animals; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; HT29 Cells; Humans; Models, Molecular; Neurodegenerative Diseases; PC12 Cells; Proteolysis; Rats; Small Molecule Libraries

2021